Archive for July, 2008
NICE restricts rheumatoid arthritis treatment options
Submitted by THE HEALTH ECONOMICS BLOG
Scrip
Patients with refractory rheumatoid arthritis in the UK who previously had the option of
three treatments will now have the option of just one, a draft appraisal from NICE has
recommended.
Patient groups and charities have reacted strongly to the final appraisal determination,
considering it tantamount to greater suffering for patients, a diminishment of [...]
New Health Economics Job Opportunities
Submitted by THE HEALTH ECONOMICS BLOG
I am posting several new positions in EU and the US both industry as well as consultancy on behalf of Simon Rose, please see his contact details below.
best wishes
Ulf
Associate Director Market Access and Pricing Europe - Switzerland
This is an excellent opportunity to join a leading, niche Biopharma based at [...]
Commentary: Pharma’s future is virtual, say Kate Moss and Dr Steve Arlington of PricewaterhouseCoopers
Submitted by THE HEALTH ECONOMICS BLOG
As pharma switches from developing palliatives to cures, its productivity in the lab is
plummeting. The number of innovative new medicines reaching the market is falling,
while the time and money required to research and develop them continue to soar, with
major strategic implications for the industry as a whole, says PricewaterhouseCoopers.
In its [...]
Reduced Cancer Drug Reimbursements Don’t Impede Access – JAMA Study
Submitted by THE HEALTH ECONOMICS BLOG
A review of Medicare claims data from 2003 through 2006 found no evidence that lowering payments to physicians for cancer drugs has adversely affected access to care.
The review by Alisa Shea and colleagues at the Duke University School of Medicine addresses concerns that the reduction in physician reimbursement mandated by [...]
The end of the industry as we know it?
Submitted by THE HEALTH ECONOMICS BLOG
Scrip
The future does not look bright, at least for those big pharma companies unable to adapt
to its new realities. The expiry of blockbuster drug patents, rising research costs and
falling product approval rates are some of the familiar woes facing the sector, but
speakers at a recent conference in Japan were in [...]
European Union on the verge of a new legislation to ease cross border medical care
Submitted by THE HEALTH ECONOMICS BLOG
from the The Wall Street Journal
European Union citizens would be able to seek medical acre anywhere in the 27-nation bloc without prior authorization and get reimbursement for the treatment by their insurer under draft rules presented by the EU executive. The guidelines are meant to ease congestion in countries with [...]
NICE launches revised guide to appraisals methodologies
Submitted by THE HEALTH ECONOMICS BLOG
The National Institute for Health and Clinical Excellence has launched a revised version of its guide to methods of appraisal.The new Guide to the Methods of Technology Appraisal replaces the previous document published in May 2004, and provides an overview of the principles and methods used by NICE to assess [...]
NICE launches revised guide to appraisals methodologies
Submitted by THE HEALTH ECONOMICS BLOG
The National Institute for Health and Clinical Excellence has launched a revised version of its guide to methods of appraisal.The new Guide to the Methods of Technology Appraisal replaces the previous document published in May 2004, and provides an overview of the principles and methods used by NICE to assess [...]
